PL1974210T3 - Sposób diagnozowania wielotorbielowatości nerek - Google Patents

Sposób diagnozowania wielotorbielowatości nerek

Info

Publication number
PL1974210T3
PL1974210T3 PL07700227T PL07700227T PL1974210T3 PL 1974210 T3 PL1974210 T3 PL 1974210T3 PL 07700227 T PL07700227 T PL 07700227T PL 07700227 T PL07700227 T PL 07700227T PL 1974210 T3 PL1974210 T3 PL 1974210T3
Authority
PL
Poland
Prior art keywords
kidney disease
polycystic kidney
diagnosing
diagnosing polycystic
pkd
Prior art date
Application number
PL07700227T
Other languages
English (en)
Inventor
Gerd Walz
Original Assignee
Univ Freiburg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Freiburg filed Critical Univ Freiburg
Publication of PL1974210T3 publication Critical patent/PL1974210T3/pl

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/34—Genitourinary disorders
    • G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Adhesive Tapes (AREA)
  • Die Bonding (AREA)
  • External Artificial Organs (AREA)
PL07700227T 2006-01-17 2007-01-17 Sposób diagnozowania wielotorbielowatości nerek PL1974210T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06000963A EP1808694A1 (en) 2006-01-17 2006-01-17 Method for diagnosing polycystic kidney disease
PCT/EP2007/000384 WO2007082733A1 (en) 2006-01-17 2007-01-17 Method for diagnosing polycystic kidney disease
EP07700227A EP1974210B1 (en) 2006-01-17 2007-01-17 Method for diagnosing polycystic kidney disease

Publications (1)

Publication Number Publication Date
PL1974210T3 true PL1974210T3 (pl) 2011-05-31

Family

ID=35945115

Family Applications (2)

Application Number Title Priority Date Filing Date
PL07700227T PL1974210T3 (pl) 2006-01-17 2007-01-17 Sposób diagnozowania wielotorbielowatości nerek
PL10196792T PL2341344T3 (pl) 2006-01-17 2007-01-17 Sposób diagnozowania wielotorbielowatości nerek

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL10196792T PL2341344T3 (pl) 2006-01-17 2007-01-17 Sposób diagnozowania wielotorbielowatości nerek

Country Status (8)

Country Link
US (1) US20110229895A1 (pl)
EP (3) EP1808694A1 (pl)
AT (1) ATE493649T1 (pl)
DE (1) DE602007011566D1 (pl)
DK (2) DK2341344T3 (pl)
ES (2) ES2356481T3 (pl)
PL (2) PL1974210T3 (pl)
WO (1) WO2007082733A1 (pl)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0710442A2 (pt) * 2006-02-09 2011-08-16 Novartis Ag agentes de ligação de proteìna-4 secretada relacionada com frizzled(sfrp-4)
EP3358354B1 (en) 2008-01-18 2020-07-15 President and Fellows of Harvard College Methods of detecting signatures of disease or conditions in bodily fluids
JP5524182B2 (ja) 2008-04-30 2014-06-18 エフ．ホフマン−ラ ロシュ アーゲー 心不全の評価におけるｓｆｒｐ−３の使用
WO2010079076A2 (de) * 2008-12-17 2010-07-15 Mosaiques Diagnostics And Therapeutics Ag Autosomal dominante polyzystische nierenerkrankung (adpkd)
WO2011057138A1 (en) * 2009-11-07 2011-05-12 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
EP2517020B1 (en) * 2009-12-23 2015-10-21 Hill's Pet Nutrition, Inc. Compositions and methods for diagnosing and treating kidney disorders in a canine
EP2596116A4 (en) 2010-07-23 2014-03-19 Harvard College METHODS FOR DETECTION OF AUTOIMMUNE OR IMMUNE-RELATED DISEASES / PATHOLOGIES
CA2806304A1 (en) 2010-07-23 2012-01-26 President And Fellows Of Harvard College Methods of detecting prenatal or pregnancy-related diseases or conditions
SG10201505724SA (en) 2010-07-23 2015-09-29 Harvard College Methods of detecting diseases or conditions using phagocytic cells
WO2012012693A2 (en) 2010-07-23 2012-01-26 President And Fellows Of Harvard College Methods for detecting signatures of disease or conditions in bodily fluids
WO2012012704A2 (en) 2010-07-23 2012-01-26 President And Fellows Of Harvard College Methods of detecting kidney-associated diseases or conditions
US9255296B2 (en) * 2011-02-24 2016-02-09 Hill's Pet Nutrition, Inc. Compositions and methods for diagnosing and treating kidney disorders in a feline
WO2014164362A1 (en) 2013-03-09 2014-10-09 Harry Stylli Methods of detecting prostate cancer
NZ771629A (en) 2013-03-09 2022-12-23 Harry Stylli Methods of detecting cancer
WO2014197729A1 (en) * 2013-06-05 2014-12-11 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
BR112017002003A2 (pt) 2014-08-04 2017-12-12 Genzyme Corp biomarcadores de doença renal policística e usos dos mesmos
WO2016040843A1 (en) 2014-09-11 2016-03-17 Harry Stylli Methods of detecting prostate cancer
AU2016233426B2 (en) * 2015-03-13 2021-08-19 Rita Maria CUNHA DE ALMEIDA Targeting cGMP-related phosphodiesterases to reduce cyst formation in cystic kidney disease, and related materials and methods
US10531837B1 (en) 2015-09-25 2020-01-14 Cerner Innovation, Inc. Predicting chronic kidney disease progression
KR20180083902A (ko) 2015-11-18 2018-07-23 젠자임 코포레이션 다낭성 신장병의 바이오마커 및 그의 용도

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0879885A1 (en) * 1997-05-23 1998-11-25 Smithkline Beecham Corporation A novel human gene similar to a secreted murine protein sFRP-1
US6638726B1 (en) * 2000-01-06 2003-10-28 Mount Sinai School Of Medicine Of New York University Screening methods for compounds useful in the treatment of polycystic kidney disease
WO2002005857A2 (en) * 2000-07-19 2002-01-24 Genzyme Corporation Phosphatonin-related gene and methods of use thereof
US20030143610A1 (en) * 2002-01-08 2003-07-31 Millennium Pharmaceuticals, Inc. Methods for the treatment of metabolic disorders, including obesity and diabetes
US7879544B2 (en) * 2002-07-29 2011-02-01 Hmgene Inc. Methods of identifying adipocyte specific genes, the genes identified, and their uses
US20040191818A1 (en) * 2003-02-26 2004-09-30 O'toole Margot Mary Compositions and methods for diagnosing and treating autoimmune diseases
WO2005070448A2 (en) * 2004-01-21 2005-08-04 Five Prime Therapeutics, Inc. Methods of use for secreted frizzled-related protein 3 (sfrp-3) in the prevention and treatment of disease
WO2005117941A2 (en) * 2004-04-29 2005-12-15 Genzyme Corporation Methods and compositions for the treatment of polycystic diseases

Also Published As

Publication number Publication date
EP1974210B1 (en) 2010-12-29
EP2341344A1 (en) 2011-07-06
WO2007082733A1 (en) 2007-07-26
DK1974210T3 (da) 2011-02-21
EP2341344B1 (en) 2014-04-30
EP1808694A1 (en) 2007-07-18
ES2475540T3 (es) 2014-07-11
DK2341344T3 (da) 2014-06-30
US20110229895A1 (en) 2011-09-22
PL2341344T3 (pl) 2014-09-30
DE602007011566D1 (en) 2011-02-10
ES2356481T3 (es) 2011-04-08
EP1974210A1 (en) 2008-10-01
ATE493649T1 (de) 2011-01-15

Similar Documents

Publication Publication Date Title
PL1974210T3 (pl) Sposób diagnozowania wielotorbielowatości nerek
WO2006020269A3 (en) Biomarkers of neurodegenerative disease
WO2010059242A3 (en) Neurodegenerative disease diagnostic compositions and methods of use
WO2007019376A3 (en) Methods and compositions for diagnosis of iga-and igm-mediated kidney diseases
WO2004112589A3 (en) Method for the detection of gene transcripts in blood and uses thereof
NO20070949L (no) Transkriptomdiagnostikk i spytt
WO2008152656A3 (en) Genetic variants on chr 15q24 as markers for use in diagnosis, prognosis and treatment of exfoliation syndrome and glaucoma
WO2009038742A3 (en) Method for estimating risk of acute kidney injury
EP2708899A3 (en) Methods and biomarkers for diagnosing and monitoring psychotic disorders
WO2007047408A3 (en) Promac signature application
WO2007114901A3 (en) Method for diagnosing adhd and related behavioral disorders
WO2008095492A3 (en) A method for diagnosing atherosclerotic plaques by measurement of cd36
WO2009059150A3 (en) Biomarkers for fatty liver disease and methods using the same
WO2008084331A3 (en) Biomarkers for renal disorders
ATE548467T1 (de) Verfahren zur identifizierung von biomarkern mit eignung bei der diagnose biologischer zustände
WO2006023412A3 (en) Biomarkers for osteoarthritis
WO2007061906A3 (en) Diagnostic and therapeutics for cardiovascular disorders
WO2007030949A3 (en) Methods of diagnosing ovarian cancer and kits therefor
WO2007106762A3 (en) Alzheimer's disease biomarkers and methods of use
WO2006138219A3 (en) Methods of diagnosis / prognosis of inflammatory conditions
WO2012178188A3 (en) Molecular diagnostic panel of eosinophilic gastrointestinal disorders
WO2006085121A3 (en) Vgp peptide fragments as biomarkers for schizophrenic and bipolar disorders
WO2005093413A3 (en) Diagnosis and treatment of preeclampsia
WO2006002240A3 (en) Computer systems and methods for constructing biological classifiers and uses thereof
WO2007106466A3 (en) Beta-2 microglobulin as a biomarker for peripheral artery disease